Reply to: Considerations on "impact of centralization of services on outcomes in a rare tumour: Retroperitoneal sarcomas".
暂无分享,去创建一个
G. Poston | H. Malik | R. Kalaiselvan | C. Chandrasekar | S. Fenwick | K. Wong | N. Ali | A. Malik | R. Rao | M. Griffin
[1] K. Hunt,et al. Treatment at low‐volume hospitals is associated with reduced short‐term and long‐term outcomes for patients with retroperitoneal sarcoma , 2018, Cancer.
[2] R. Abouassaly,et al. Predictors of surgical quality for retroperitoneal sarcoma: Volume matters , 2017, Journal of surgical oncology.
[3] C. D. Fletcher,et al. Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group , 2016, Annals of Surgical Oncology.
[4] T. Group,et al. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group , 2014, Annals of Surgical Oncology.
[5] J. Blay,et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Mussi,et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.